Histopathologic Characterization of Myocarditis Associated With Immune Checkpoint Inhibitor Therapy.

Archives of Pathology & Laboratory Medicine
Irina SobolAlain C Borczuk

Abstract

Cardiac complications of immune checkpoint inhibitor therapy are rare, but reports of myocarditis are increasing. The findings have been described in case reports as lymphocytic myocarditis, but its histopathology is underreported. To review the histology of myocardial biopsy-proven cases of immune checkpoint-associated myocarditis and provide immunohistochemical characterization of the inflammatory infiltrate. We have encountered 6 patients with biopsy-proven myocarditis in conjunction with therapy using anti-programmed death receptor-1 (PD-1)/programmed death ligand-1 (PD-L1) agents with and without cytotoxic T-lymphocyte associated protein 4 (CTLA-4) inhibitors and characterized the histopathology and immune cell profile. The myocarditis was multifocal/diffuse and characterized by a predominant CD163-positive histiocytic infiltrate, with an associated CD8+ and PD-1+ T-lymphocytic infiltrate, some of which were granzyme B positive. Cardiac myocytes showed immunoreactivity for PD-L1 in areas of injury, confirmed using 2 different anti-PD-L1 clones. Four of 6 patients recovered from their cardiac injury. One patient had residual tachycardia-bradycardia syndrome and 1 patient expired. The diffuse lymphohistiocytic myocarditis as...Continue Reading

References

Jun 1, 1987·Human Pathology·H T Aretz
Apr 22, 2015·The New England Journal of Medicine·Michael A PostowF Stephen Hodi
Apr 23, 2015·Journal for Immunotherapy of Cancer·Heinz LäubliAlfred Zippelius
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Mar 17, 2016·Journal for Immunotherapy of Cancer·Viktor H KoelzerKirsten D Mertz
Apr 20, 2016·The New England Journal of Medicine·Paul T NghiemMartin A Cheever
Aug 18, 2016·Journal for Immunotherapy of Cancer·Lucie HeinzerlingJason J Luke
Aug 28, 2016·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·H SemperC Grohé
Sep 22, 2016·Circulation. Heart Failure·Tomonori TadokoroMasahiro Mohri
Nov 3, 2016·The New England Journal of Medicine·Douglas B JohnsonJavid J Moslehi
Aug 24, 2017·Journal of Forensic Sciences·Daniel R MatsonRobert F Corliss
Oct 19, 2017·Japanese Journal of Clinical Oncology·Kazuko TajiriIkuo Sekine
Jan 23, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael J OvermanThierry André
Mar 15, 2018·Lancet·Javid J MoslehiDouglas B Johnson
Mar 24, 2018·Journal of the American College of Cardiology·Syed S MahmoodTomas G Neilan
May 16, 2018·Cancer Cell·Martin Früh, Solange Peters
May 29, 2018·The Canadian Journal of Cardiology·Shogo YamaguchiToyoaki Murohara
Jun 21, 2018·Gynecologic Oncology Reports·Syed S MahmoodVicky Makker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Related Papers

Giornale italiano di cardiologia
M Frigerio, T Morgera
Kardiologiia
M A Gurevich, M O Iankovskaia
JAMA : the Journal of the American Medical Association
V I Adams
Circulation
C E DE LA CHAPELLE, C E KOSSMANN
© 2021 Meta ULC. All rights reserved